1443998-09-1

Basic information

• Product Name: C₃₃H₂₄ClN₅O₇
• Synonyms: C₃₃H₂₄ClN₅O₇
• CAS NO: 1443998-09-1
• Molecular Weight: 638.036
• Mol File: 1443998-09-1.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: C₃₃H₂₄ClN₅O₇(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₃H₂₄ClN₅O₇(1443998-09-1)
• EPA Substance Registry System: C₃₃H₂₄ClN₅O₇(1443998-09-1)

Safety Data

• Hazardous Substances Data: 1443998-09-1(Hazardous Substances Data)

Upstream product

• 1443997-54-3 (2R,3R,4R,5R)-5-((benzoyloxy)methyl)-3-ethynyltetrahydrofuran-2,3,4-triyl tribenzoate 
• 10310-21-1 2-amino-6-chloropurine 
• 157037-56-4 1,3,5-tri-O-benzoyl-2-oxo-α-D-erythro-pentofuranose 
• 69339-86-2 1,2,3,5-tetra-O-benzoyl-α-D-ribofuranoside 
• 10310-21-1 2-Amino-6-chloropurin 

Downstream Products

• 1443998-10-4 C₅₃H₄₀ClN₅O₈ 
• 1613589-32-4 C₃₉H₃₅N₅O₈S 
• 1613589-33-5 5'-deoxy-5'-iodo-2'-C-ethynyl-N²-(methoxytrityl)guanosine 
• 1613589-34-6 4',5'-didehydro-5'-deoxy-2'-C-ethynyl-N²-(methoxytrityl)guanosine 
• 1613589-35-7 C₃₂H₂₇FIN₅O₅ 
• 1613589-36-8 C₄₆H₃₅FIN₅O₇ 
• 1613589-37-9 4'-fluoro-2',3',5'-tri-O-benzoyl-2'-C-ethynyl-N²-(methoxytrityl)guanosine 
• 1613589-38-0 4'-fluoro-2'-C-ethynyl-N²-(methoxytrityl)guanosine 
• 1613589-40-4 C₃₄H₃₃N₅O₆ 
• 1613589-41-5 C₄₁H₃₉N₅O₈S 
• 1613589-42-6 C₃₄H₃₂IN₅O₅ 
• 1613589-43-7 C₃₄H₃₁N₅O₅ 
• 1613589-44-8 C₃₄H₃₁FIN₅O₅ 
• 1613589-45-9 C₄₈H₃₉FIN₅O₇ 

Relevant articles and documents

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

Disclosed herein are nucleosides, nucleotides and nucleotide analogs, methods of synthesizing the same and methods of treating diseases and/or conditions such as a Coronaviridae virus, a Togaviridae virus, a Hepeviridae virus and/or a Bunyaviridae virus infection with one or more nucleosides, nucleotides and nucleotide analogs.

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

Disclosed herein are nucleosides, nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a Filoviridae virus infection with one or more nucleosides and/or nucleotide analogs.

SUBSTITUTED NUCLEOTIDE ANALOGS

Disclosed herein are phosphorothioate nucleotide analogs, methods of synthesizing phosphorothioate nucleotide analogs and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with the phosphorothioate nucleotide analogs.